Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.

Takimoto, Chris H

Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jul 2003 - 2664-72 p. digital

Publication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.

0732-183X

10.1200/JCO.2003.11.015 doi


Adult
Aged
Aged, 80 and over
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Follow-Up Studies
Glomerular Filtration Rate--drug effects
Humans
Infusions, Intravenous
Kidney Diseases--physiopathology
Kidney Function Tests
Male
Maximum Tolerated Dose
Middle Aged
National Institutes of Health (U.S.)
Neoplasm Staging
Neoplasms--drug therapy
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Probability
Reference Values
Risk Assessment
Severity of Illness Index
Survival Analysis
Treatment Outcome
United States